What is the current price and volume for ALNEV.PA stock?

ALNEV.PA stock is trading at €0.0016 with intraday volume of 13,182,864 shares on EURONEXT. The day range is €0.0015 to €0.0018 and average volume is about 8,154,160.

Why is ALNEV.PA stock priced so low despite book value?

ALNEV.PA stock shows a low market price due to chronic operating losses (EPS -221.36), cash burn (operating cash flow per share -20.64), low liquidity and risk of dilution, despite high book value per share.

What catalysts could move ALNEV.PA stock higher?

Clinical trial readouts for IFNa Kinoid, new licensing deals, or meaningful capital raises could push ALNEV.PA stock higher. Expect sharp moves on any confirmed positive trial news or strategic partnerships.

How does Meyka AI view ALNEV.PA stock for investors?

Meyka AI assigns ALNEV.PA a **61.87** score (Grade B, HOLD) based on benchmarks, sector, growth and metrics. This grade is informational; investors should weigh clinical risk and low liquidity before allocating capital.

EU Stocks

Heavy intraday volume: ALNEV.PA Neovacs S.A. EURONEXT 17 Feb 2026: trade setup

ByHuzaifa Zahoor February 17, 2026February 17, 2026

ALNEV.PA stock is among today’s most active names as Neovacs S.A. trades at €0.0016 on EURONEXT with 13,182,864 shares changing hands intraday. The tiny price and unusually high volume make ALNEV.PA stock a volatility play in the Healthcare biotechnology group. Intraday range sits between €0.0015 and €0.0018, and the 50-day average is about €0.0067, highlighting steep recent weakness. We summarise the drivers behind volume, the technical picture, and where analysts and our models place a 12-month outlook for ALNEV.PA stock.